BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16516257)

  • 21. Mouse adenovirus type 1 attachment is not mediated by the coxsackie-adenovirus receptor.
    Lenaerts L; Daelemans D; Geukens N; De Clercq E; Naesens L
    FEBS Lett; 2006 Jul; 580(16):3937-42. PubMed ID: 16806202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice.
    Gu DL; Gonzalez AM; Printz MA; Doukas J; Ying W; D'Andrea M; Hoganson DK; Curiel DT; Douglas JT; Sosnowski BA; Baird A; Aukerman SL; Pierce GF
    Cancer Res; 1999 Jun; 59(11):2608-14. PubMed ID: 10363982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats.
    Nicol CG; Graham D; Miller WH; White SJ; Smith TA; Nicklin SA; Stevenson SC; Baker AH
    Mol Ther; 2004 Aug; 10(2):344-54. PubMed ID: 15294181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity.
    Yun CO; Yoon AR; Yoo JY; Kim H; Kim M; Ha T; Kim GE; Kim H; Kim JH
    Hum Gene Ther; 2005 Feb; 16(2):248-61. PubMed ID: 15761264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.
    Fechner H; Haack A; Wang H; Wang X; Eizema K; Pauschinger M; Schoemaker R; Veghel R; Houtsmuller A; Schultheiss HP; Lamers J; Poller W
    Gene Ther; 1999 Sep; 6(9):1520-35. PubMed ID: 10490761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
    Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
    J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent antietumor immunity in mice induced by vaccination with an ovine atadenovirus vector.
    Tang R; Li K; Wilson M; Both GW; Taylor JA; Young SL
    J Immunother; 2012 Jan; 35(1):32-41. PubMed ID: 22130165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors.
    Haviv YS; Blackwell JL; Kanerva A; Nagi P; Krasnykh V; Dmitriev I; Wang M; Naito S; Lei X; Hemminki A; Carey D; Curiel DT
    Cancer Res; 2002 Aug; 62(15):4273-81. PubMed ID: 12154029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function.
    Davison E; Kirby I; Whitehouse J; Hart I; Marshall JF; Santis G
    J Gene Med; 2001; 3(6):550-9. PubMed ID: 11778901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity.
    Koizumi N; Kawabata K; Sakurai F; Watanabe Y; Hayakawa T; Mizuguchi H
    Hum Gene Ther; 2006 Mar; 17(3):264-79. PubMed ID: 16544976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient delivery and stable gene expression in a hematopoietic cell line using a chimeric serotype 35 fiber pseudotyped helper-dependent adenoviral vector.
    Balamotis MA; Huang K; Mitani K
    Virology; 2004 Jun; 324(1):229-37. PubMed ID: 15183069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases.
    Shayakhmetov DM; Li ZY; Ni S; Lieber A
    Cancer Res; 2002 Feb; 62(4):1063-8. PubMed ID: 11861383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity.
    Ophorst OJ; Kostense S; Goudsmit J; De Swart RL; Verhaagh S; Zakhartchouk A; Van Meijer M; Sprangers M; Van Amerongen G; YĆ¼ksel S; Osterhaus AD; Havenga MJ
    Vaccine; 2004 Aug; 22(23-24):3035-44. PubMed ID: 15297053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation in fiber of adenovirus serotype 5 gene therapy vector decreases liver tropism.
    Wang Z; Wang B; Lou J; Yan J; Gao L; Geng R; Yu B
    Int J Clin Exp Med; 2014; 7(12):4942-50. PubMed ID: 25663991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy.
    Lewis TB; Glasgow JN; Glandon AM; Curiel DT; Standaert DG
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free cholesterol enhances adenoviral vector gene transfer and expression in CAR-deficient cells.
    Worgall S; Worgall TS; Kostarelos K; Singh R; Leopold PL; Hackett NR; Crystal RG
    Mol Ther; 2000 Jan; 1(1):39-48. PubMed ID: 10933910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts.
    Hidaka C; Milano E; Leopold PL; Bergelson JM; Hackett NR; Finberg RW; Wickham TJ; Kovesdi I; Roelvink P; Crystal RG
    J Clin Invest; 1999 Feb; 103(4):579-87. PubMed ID: 10021467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice.
    Smith TA; Idamakanti N; Rollence ML; Marshall-Neff J; Kim J; Mulgrew K; Nemerow GR; Kaleko M; Stevenson SC
    Hum Gene Ther; 2003 May; 14(8):777-87. PubMed ID: 12804140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic retargeting of adenovirus: novel strategy employing "deknobbing" of the fiber.
    Magnusson MK; Hong SS; Boulanger P; Lindholm L
    J Virol; 2001 Aug; 75(16):7280-9. PubMed ID: 11462000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.